Finance

Lists
Why is INTI up 12.14%?
Dive Deeper
INTI:OTCMKTS
Inhibitor Therapeutics Inc
$0.11
+12.14%
(+0.012) 1D
Oct 16, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INTI...
Open
$0.07
High
$0.11
Low
$0.06
Mkt. cap
19.10M
Avg. vol.
1.74K
Volume
3.86K
52-wk high
$0.12
52-wk low
$0.04
EPS
-$0.02
Beta
-0.44
Shares outstanding
173.79M
No. of employees
5
Open
$0.07
High
$0.11
Low
$0.06
Mkt. cap
19.10M
Avg. vol.
1.74K
Volume
3.86K
52-wk high
$0.12
52-wk low
$0.04
EPS
-$0.02
Beta
-0.44
Shares outstanding
173.79M
No. of employees
5
News stories
From web sources and news partners
About Inhibitor Therapeutics Inc
CEO-
Employees5
Founded1992
HeadquartersTampa, Florida, United States
SectorBiotechnology
Websiteinhibitortx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
377.79K
757.25K
340.56K
223.56K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
363.43K
557.87K
355.07K
395.03K
Operating expense
741.22K
1.32M
695.63K
618.60K
Total operating expenses
741.22K
1.32M
695.63K
618.60K
Operating income
-741.22K
-1.32M
-695.63K
-618.60K
Other non operating income
-
-
-
-
EBT including unusual items
-712.18K
-1.30M
-686.42K
-613.93K
EBT excluding unusual items
-712.18K
-1.30M
-686.42K
-613.93K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-712.18K
-1.30M
-686.42K
-613.93K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
29.03K
19.75K
9.21K
4.66K
Interest expense
-
-
-
-
Net interest expenses
29.03K
19.75K
9.21K
4.66K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps